Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.
Psilocybin recently received breakthrough status by the FDA for its use in treatment of depression. We therefore investigated mental health professionals (MHPs) opinions on Psilocybin (n 155). Overall, attitudes were neutral but self-rated knowledge of Psilocybin was low. The term used in the survey, Psilocybin or Magic Mushrooms, did not significantly affect their responses. Some variables (i.e., gender, attitudes towards medical cannabis, and personal history of psychedelic usage) were associated with ratings of Psilocybin. These results provide a baseline of MHPs thoughts on Psilocybin and what should be considered in the future if it is FDA-approved.